Apellis Pharmaceuticals Inc CO Com
Apellis Pharmaceuticals Inc CO Com is a security (CUSIP 037CVR016) tracked across SEC portfolio filings. 4 institutional managers reported positions on Form 13F as of 2026-06-30; 3 registered fund positions totaling $8K via N-PORT as of 2026-05-31.
Summary
- Issuer: Apellis Pharmaceuticals Inc CO
- Class: Com
- CUSIP: 037CVR016
- Asset category: DE
- 13F holders: 4
- 13F period: 2026-06-30
- N-PORT fund positions: 3
- N-PORT value: $8K
- N-PORT report: 2026-05-31
Top institutional holders (Form 13F)
Top fund holders (N-PORT)
More